Ist eine kostenreduktion in der flussigkeitstherapie bei wahrung der qualitat in der intensivtherapie moglich?

Translated title of the contribution: Is there a way for cost reduction in fluid therapy without a loss in quality

Th Prien, Kai Singbartl

Research output: Contribution to journalArticle


Cost reduction in fluid therapy may be possible without a loss in quality of medical therapy if the following principles are adhered to. 1: Compare the prices of different manufacturers. 2: The greater the product unit, the cheaper the milliliter. Adherence to this principle is limited by hygienic and logistic considerations. 3: 0.9% NaCl-solution is cheaper than Ringer's lactate-solution. Lactated Ringer's solution should be used, only, if there are contraindications against the higher solute concentrations and tonicity of 0.9% NaCl. 4: Crystalloids are cheaper than colloids. When choosing between these two options intravasal duration of action and specific adverse events must be considered. 5: Cost reduction by differential indication of artificial colloids. Comparing prices, one must consider risk of anaphylactoid/anaphylactic reactions, duration of action, limitation of dosage and possible hemostasis disorders. 6: Restrictive use of albumin. Albumin is the most expensive colloid. There are no reasons for routine use.

Original languageGerman
Pages (from-to)395-399
Number of pages5
Issue number5
Publication statusPublished - Jun 15 1998


All Science Journal Classification (ASJC) codes

  • Anesthesiology and Pain Medicine

Cite this